Epidemiology of Intracranial Meningioma, Neurosurgery, vol.7, issue.6, pp.1088-1095, 2005. ,
DOI : 10.1269/jrr.40.49
Childhood and juvenile meningiomas, Child's Nervous System, vol.11, issue.255, pp.1571-1580, 2009. ,
DOI : 10.1016/S0344-0338(00)80050-3
Histological typing of tumours of the central nervous system. World Health Organization, 1979. ,
World Health Organization Classification of Tumours. Pathology and genetics. Tumour of the nervous system, pp.175-184, 2000. ,
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary, Acta Neuropathologica, vol.45, issue.6, p.2016 ,
DOI : 10.1038/ng.2611
URL : https://hal.archives-ouvertes.fr/hal-01479018
Epidemiology of meningiomas, Neurochirurgie, vol.64, issue.1 ,
DOI : 10.1016/j.neuchi.2014.05.006
Analyse du devenir post-opératoire des méningiomes intracrâniens ,
Recensement national histologique des tumeurs primitives du syst??me nerveux central??: r??sultats g??n??raux sur 40??000??cas, principales applications actuelles et perspectives, Neurochirurgie, vol.58, issue.1, pp.4-13, 2012. ,
DOI : 10.1016/j.neuchi.2012.01.004
URL : https://doi.org/10.1016/j.neuchi.2012.01.004
Clinicopathological variables, immune phenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II, Histol Histopathol, vol.25, pp.341-349, 2010. ,
Long-Term Outcome After Radiotherapy in Patients With Atypical and Malignant Meningiomas???Clinical Results in 85 Patients Treated in a Single Institution Leading to Optimized Guidelines for Early Radiation Therapy, International Journal of Radiation Oncology*Biology*Physics, vol.83, issue.3, pp.859-864, 2012. ,
DOI : 10.1016/j.ijrobp.2011.08.010
EANO guidelines for the diagnosis and treatment of meningiomas, The Lancet Oncology, vol.17, issue.9, pp.383-91, 2016. ,
DOI : 10.1016/S1470-2045(16)30321-7
Meningiomas, The Lancet, vol.363, issue.9420, pp.1535-1578, 2004. ,
DOI : 10.1016/S0140-6736(04)16153-9
Les m??ningiomes rachidiens extraduraux : Donn??es IRM ?? propos de deux observations, Journal of Neuroradiology, vol.31, issue.3, pp.31214-219, 2004. ,
DOI : 10.1016/S0150-9861(04)96994-5
Distant metastases in meningioma: an underestimated problem Journal of Neuro-Oncology, pp.323-327, 2013. ,
Metastasis in meningioma Neuropathologies des tumeurs intra-crâniennes http, Acta Neurochirurgica, vol.13817, issue.10, pp.1172-1178, 1996. ,
Données générales de neuro-oncogenèse, pp.75-89, 2004. ,
Cytological and cytogenetical studies on brain tumors, Humangenetik, vol.12, issue.2, pp.167-169, 1972. ,
DOI : 10.1007/BF00273305
Meningioma Genomics: Diagnostic, Prognostic, and Therapeutic Applications, Frontiers in Surgery, vol.19, issue.19, p.40, 2016. ,
DOI : 10.1158/1078-0432.CCR-13-0143
Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: Toward a genetic model of meningioma progression, Proceedings of the National Academy of Sciences, vol.56, issue.11, pp.9414719-14724, 1997. ,
DOI : 10.1038/ng0495-401
Molecular genetics of meningiomas: Building the roadmap towards personalized therapy, Neurochirurgie, vol.64, issue.1, 2014. ,
DOI : 10.1016/j.neuchi.2014.06.007
Shedding light on Merlin's wizardry, Trends in Cell Biology, vol.17, issue.5, 2007. ,
DOI : 10.1016/j.tcb.2007.03.006
Intracranial meningiomas: an overview of diagnosis and treatment, Neurosurgical Focus, vol.345, issue.3, p.1, 2007. ,
DOI : 10.1002/1097-0142(20000901)89:5<1102::AID-CNCR20>3.0.CO;2-L
Modern meningioma imaging techniques, Journal of Neuro-Oncology, vol.50, issue.1, pp.333-340, 2010. ,
DOI : 10.1007/s11060-010-0367-6
URL : https://link.springer.com/content/pdf/10.1007%2Fs11060-010-0367-6.pdf
Expression of vascular endothelial growth factor in human meningiomas and peritumoral brain areas, Ann Clin Lab Sci. Autumn, vol.38, issue.4, pp.344-51, 2008. ,
Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature review, Journal of Neurosurgery, vol.8, issue.3, pp.660-669, 2017. ,
DOI : 10.1073/pnas.1102198108
URL : https://hal.archives-ouvertes.fr/hal-01478922
Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma, Neuropathology, vol.20, issue.2, pp.114-134, 2007. ,
DOI : 10.1007/BF01476410
Advances in meningioma genetics: novel therapeutic opportunities, Nature Reviews Neurology, vol.11, issue.2, 2018. ,
DOI : 10.1016/j.ccr.2013.01.008
Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas, Nature Genetics, vol.12, issue.3, pp.295-303, 2013. ,
DOI : 10.1002/lary.20430
Loss of SUFU Function in Familial Multiple Meningioma, The American Journal of Human Genetics, vol.91, issue.3, pp.520-526, 2012. ,
DOI : 10.1016/j.ajhg.2012.07.015
Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas, Journal of Medical Genetics, vol.48, issue.2, pp.93-100, 2011. ,
DOI : 10.1136/jmg.2010.082420
URL : https://hal.archives-ouvertes.fr/hal-00573999
Neurofibromatosis type 2, The Lancet, vol.373, issue.9679, pp.1974-1986, 2009. ,
DOI : 10.1016/S0140-6736(09)60259-2
Molecular genetics of meningiomas: Building the roadmap towards personalized therapy, Neurochirurgie, vol.64, issue.1, 2014. ,
DOI : 10.1016/j.neuchi.2014.06.007
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations, Nature Genetics, vol.146, issue.3, pp.285-289, 2013. ,
DOI : 10.1038/nature09534
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, Science, vol.4339, pp.1077-1080, 2013. ,
Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma, Neuro Oncol, 2016. ,
TERT Promoter Mutations and Risk of Recurrence in Meningioma, Journal of the National Cancer Institute, vol.125, issue.3, 2016. ,
DOI : 10.1007/s00401-014-1370-3
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas, Nature Genetics, vol.37, issue.10, pp.1253-1259, 2016. ,
DOI : 10.1093/nar/gkp335
Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression, Cancer Res, vol.53, pp.2386-2392, 1993. ,
Analysis of the PTEN gene in human meningiomas, Neuropathology and Applied Neurobiology, vol.146, issue.1, pp.3-8, 1998. ,
DOI : 10.3171/jns.1992.77.2.0295
Molecular pathogenesis of meningiomas, Journal of Neuro-Oncology, vol.92, issue.Suppl1, pp.183-202, 2004. ,
DOI : 10.1016/S0002-9440(10)64222-8
TRAF7 Potentiates MEKK3-induced AP1 and CHOP Activation and Induces Apoptosis, Journal of Biological Chemistry, vol.115, issue.17, p.17278, 2004. ,
DOI : 10.1038/ncb1086
URL : http://www.jbc.org/content/279/17/17278.full.pdf
The Emerging Role of TRAF7 in Tumor Development, Journal of Cellular Physiology, vol.286, issue.6, pp.1233-1238, 2017. ,
DOI : 10.1074/jbc.M110.215426
A transforming mutation in the pleckstrin homology domain of AKT1 in cancer, Nature, vol.1, issue.7152, pp.439-483, 2007. ,
DOI : 10.1128/MCB.17.1.338
The Hedgehog's tale: developing strategies for targeting cancer, Nature Reviews Cancer, vol.137, issue.7, pp.493-501, 2011. ,
DOI : 10.1242/dev.056358
Genetic landscape of meningioma, Brain Tumor Pathology, vol.22, issue.4, pp.237-247, 2016. ,
DOI : 10.1097/PAI.0b013e318289f490
Frequency of TERT promoter mutations in human cancers, Nature Communications, vol.30, p.2185, 2013. ,
DOI : 10.1038/onc.2010.512
PTEN and the PI3-Kinase Pathway in Cancer, Annual Review of Pathology: Mechanisms of Disease, vol.4, issue.1, pp.127-150, 2009. ,
DOI : 10.1146/annurev.pathol.4.110807.092311
Advances in meningioma genetics: novel therapeutic opportunities, Nature Reviews Neurology, vol.11, issue.2, 2017. ,
DOI : 10.1016/j.ccr.2013.01.008
SMO mutation status defines a distinct and frequent molecular subgroup in olfactory groove meningiomas. Neuro Oncol, pp.345-351, 2017. ,
Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence, Neuro-Oncology, vol.125, issue.3, pp.1088-1096, 2017. ,
DOI : 10.1007/s00401-013-1093-x
Cell-free DNA in the blood as a solid tumor biomarker???A critical appraisal of the literature, Clinica Chimica Acta, vol.411, issue.21-22, pp.1611-1624, 2010. ,
DOI : 10.1016/j.cca.2010.07.032
Quel avenir pour l???ADN tumoral circulant??? ??tat des lieux et perspectives dans les cancers colorectaux, pulmonaires non ?? petites cellules et pancr??atiques, Bulletin du Cancer, vol.103, issue.1, 2016. ,
DOI : 10.1016/j.bulcan.2015.10.017
Intérêts de l'ADN circulant pour la prise en charge du cancer bronchopulmonaire, Rev Pneumol Clin, 2015. ,
DOI : 10.1016/j.pneumo.2015.05.001
Is the role of circulating DNA as a biomarker of cancer being prematurely overrated? Clin Biochem, pp.26-36, 2010. ,
Assessment of DNA Integrity, Applications for Cancer Research, Adv Clin Chem, vol.70, pp.197-246, 2015. ,
DOI : 10.1016/bs.acc.2015.03.002
Circulating Cell-Free DNA: The Blood Biopsy in Cancer Management, MOJ Cell Sci Rep, vol.2, 2015. ,
High-sensitivity sequencing reveals multi-organ somatic mosaicism causing DICER1 syndrome, J. Med. Genet, p.2016 ,
Detection and quantification of rare mutations with massively parallel sequencing, Proceedings of the National Academy of Sciences, vol.323, issue.5910, pp.9530-9535, 2011. ,
DOI : 10.1126/science.1162986
Computational tools for copy number variation (CNV) detection using next-generation sequencing data: features and perspectives, BMC Bioinformatics, vol.14, issue.Suppl 11, p.14, 2013. ,
DOI : 10.1186/1471-2105-12-267
Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer, The Journal of Molecular Diagnostics, vol.19, issue.1, pp.4-23, 2017. ,
DOI : 10.1016/j.jmoldx.2016.10.002
Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord, Proceedings of the National Academy of Sciences, vol.4, issue.4, 2015. ,
DOI : 10.1126/science.1210557
DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis, The Lancet Oncology, vol.18, issue.5, 2017. ,
DOI : 10.1016/S1470-2045(17)30155-9